The Current State of Treatment for Cannabis Use Disorder
DOI:
https://doi.org/10.12775/JEHS.2022.12.08.026Keywords
cannabis, cannabis use disorder, treatment, psychotherapy, pharmacotherapiesAbstract
Cannabis remains the most commonly used illicit psychoactive drug and contains substances that affect the brain and body. A range of acute and chronic health problems associated with cannabis use has been identified.
Cannabis use disorder is defined as the continued use of cannabis despite clinically significant impairment. It is estimated that 1 in 10 people who use marijuana will become addicted. CUD is a problematic pattern of cannabis use that causes clinically significant impairment. There is not an available medication to successfully treat CUD, but psychotherapeutic models hold promise. Cognitive behavioural therapy, motivational enhancement therapy and contingency management can substantially reduce cannabis use and cannabis-related problems.
The legalization of non-medical cannabis use in some high-income countries may increase the prevalence of CUD. Since this approach has not yet been validated for CUD, the improvement of psychosocial treatments with pharmacological therapies should be further explored in future clinical research.
References
Burggren AC, Shirazi A, Ginder N, London ED. Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives. Am J Drug Alcohol Abuse. 2019;45(6):563-579. doi:10.1080/00952990.2019.1634086
Substance Abuse and Mental Health Services Administration, Know the Risks of Marijuana. Available online: https://www.samhsa.gov/marijuana (accessed on 25 July 2022).
ICD-10 Version:2016 https://icd.who.int/browse10/2016/en#/F12 (accessed on 25 July 2022).
ICD-11 for Mortality and Morbidity Statistics https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/1913137404 (accessed on 25 July 2022).
Zehra A, Burns J, Liu C, et al. Cannabis addiction and the brain: a review. J Neuroimmune Pharmacol. 2018;13:438-52. doi:10.1007/s11481-018-9782-9
Hasin DS, Kerridge BT, Saha TD, et al. Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Am J Psychiatry. 2016;173(6):588-599. doi:10.1176/appi.ajp.2015.15070907
Cougle JR, Hakes JK, Macatee RJ, Zvolensky MJ, Chavarria J. Probability and correlates of dependence among regular users of alcohol, nicotine, cannabis, and cocaine: concurrent and prospective analyses of the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2016;77(4):e444-e450. doi:10.4088/JCP.14m09469
Connor J, Stjepanovic D, Le Foll B, Hoch E, Budney A, Hall W. Cannabis use and cannabis use disorder. Nature Rev Disease Primers. 2021;7(16). doi:10.1038/s41572-021-00247-4
NIDA. 2021, April 13. Available Treatments for Marijuana Use Disorders. https://nida.nih.gov/publications/research-reports/marijuana/available-treatments-marijuana-use-disorders (accessed on July 25)
Nielsen S, Gowing L, Sabioni P, Le Foll B. Pharmacotherapies for cannabis dependence. Cochrane Database Syst Rev. 2019;1(1):CD008940. Published 2019 Jan 28. doi:10.1002/14651858.CD008940.pub3
Hodgins DC, Stea JN. Insights from individuals successfully recovered from cannabis use disorder: Natural versus treatment-assisted recoveries and abstinent versus moderation outcomes. Addiction Science & Clinical Practice. 2018;13(16). doi:10.1186/s13722-018-0118-0
Schaub M, Wenger A, Berg O, et al. A web-based self-help intervention with and without chat counseling to reduce cannabis use in problematic cannabis users: three-arm randomized controlled trial. J Med Internet Res. 2015;17(10):e232.
Buchowski MS, Meade NN, Charboneau E, et al. Aerobic exercise training reduces cannabis craving and use in non-treatment seeking cannabis-dependent adults. PLoS One. 2011;6(3):e17465. Published 2011 Mar 8. doi:10.1371/journal.pone.0017465
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Joanna Dmochowska, Eryk Mikos, Karol Kanon, Sara Moqbil, Martyna Wasyluk
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 552
Number of citations: 0